BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 25659870)

  • 1. Nuclear receptors and cholesterol metabolism in the intestine.
    Moschetta A
    Atheroscler Suppl; 2015 Feb; 17():9-11. PubMed ID: 25659870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.
    Uppal H; Zhai Y; Gangopadhyay A; Khadem S; Ren S; Moser JA; Xie W
    Hepatology; 2008 Apr; 47(4):1331-42. PubMed ID: 18318438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice.
    de Boer JF; Schonewille M; Boesjes M; Wolters H; Bloks VW; Bos T; van Dijk TH; Jurdzinski A; Boverhof R; Wolters JC; Kuivenhoven JA; van Deursen JM; Oude Elferink RPJ; Moschetta A; Kremoser C; Verkade HJ; Kuipers F; Groen AK
    Gastroenterology; 2017 Apr; 152(5):1126-1138.e6. PubMed ID: 28065787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male mice.
    Sugizaki T; Watanabe M; Horai Y; Kaneko-Iwasaki N; Arita E; Miyazaki T; Morimoto K; Honda A; Irie J; Itoh H
    Endocrinology; 2014 Aug; 155(8):2810-9. PubMed ID: 24773344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors.
    Redinger RN
    Can J Gastroenterol; 2003 Apr; 17(4):265-71. PubMed ID: 12704471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home?
    Ory DS
    Circ Res; 2004 Oct; 95(7):660-70. PubMed ID: 15459087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions of Cholesterol Metabolites.
    Sato R
    J Nutr Sci Vitaminol (Tokyo); 2015; 61 Suppl():S151-3. PubMed ID: 26598835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis.
    Edwards PA; Kast HR; Anisfeld AM
    J Lipid Res; 2002 Jan; 43(1):2-12. PubMed ID: 11792716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR.
    Handschin C; Meyer UA
    Arch Biochem Biophys; 2005 Jan; 433(2):387-96. PubMed ID: 15581595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.
    Degirolamo C; Modica S; Vacca M; Di Tullio G; Morgano A; D'Orazio A; Kannisto K; Parini P; Moschetta A
    Hepatology; 2015 Jan; 61(1):161-70. PubMed ID: 24954587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ezetimibe on cholesterol absorption and lipoprotein composition in diabetes and metabolic syndrome.
    Federici M
    Atheroscler Suppl; 2015 Feb; 17():17-22. PubMed ID: 25659872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases.
    Niesor EJ; Flach J; Lopes-Antoni I; Perez A; Bentzen CL
    Curr Pharm Des; 2001 Mar; 7(4):231-59. PubMed ID: 11254888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.
    Repa JJ; Turley SD; Lobaccaro JA; Medina J; Li L; Lustig K; Shan B; Heyman RA; Dietschy JM; Mangelsdorf DJ
    Science; 2000 Sep; 289(5484):1524-9. PubMed ID: 10968783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary procyanidins selectively modulate intestinal farnesoid X receptor-regulated gene expression to alter enterohepatic bile acid recirculation: elucidation of a novel mechanism to reduce triglyceridemia.
    Heidker RM; Caiozzi GC; Ricketts ML
    Mol Nutr Food Res; 2016 Apr; 60(4):727-36. PubMed ID: 26718753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes.
    González-Regueiro JA; Moreno-Castañeda L; Uribe M; Chávez-Tapia NC
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):16-21. PubMed ID: 29118282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
    Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
    Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders.
    Fiorucci S; Mencarelli A; Palladino G; Cipriani S
    Trends Pharmacol Sci; 2009 Nov; 30(11):570-80. PubMed ID: 19758712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
    Fiévet C; Staels B
    Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nuclear receptor LXR is a glucose sensor.
    Mitro N; Mak PA; Vargas L; Godio C; Hampton E; Molteni V; Kreusch A; Saez E
    Nature; 2007 Jan; 445(7124):219-23. PubMed ID: 17187055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.